地中海饮食与SUN项目中成人喘发病率之间的关联:西班牙前性队列研究
Javier Errasti Viader1,2, Carmen de la Fuente-Arrillaga1,3,4, Arantza Campo Ezquibela5
1Department of Preventive Medicine and Public Health, University of Navarra-IDISNA, Pamplona, Spain.
概括
坚持地中海饮食 (MedDiet) 可能会降低喘风险. 这项研究发现,坚持MedDiet的成年人患喘发病率显著降低. 关键词:地中海饮食,喘,发病率,成年人.
科学领域:
- 营养科学 营养科学
- 流行病学 流行病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 饮食因素与喘的发展有关,但证据仍然没有确定性.
- 地中海饮食 (MedDiet) 是一种与各种健康益处相关的饮食模式.
- 调查MedDiet在成人发作喘中的作用至关重要.
研究的目的:
- 检查遵守地中海饮食 (MedDiet) 与成人喘发病率之间的关联.
- 探索饮食模式作为潜在的可修改喘风险因素.
主要方法:
- 利用了来自SUN队列研究 (Seguimiento Universidad de Navarra) 的数据,包括饮食习惯和喘诊断.
- 定义成人发作的喘是自报的诊断在基线无呼吸道疾病的成年人.
- 通过使用食物频率问卷评估饮食习惯,并计算地中海饮食得分 (MDS) 以确保遵守.
- 采用多变量重复测量考克斯模型来分析MDS和喘发病率之间的关联.
主要成果:
- 一组17,127名参与者被跟踪平均12.8年,其中302名 (1.76%) 患有新发喘.
- 较高的MedDiet坚持与较低的新诊断喘风险显著相关.
- 与最低的坚持 (MDS ≤2) 组相比,坚持最高的组 (MDS ≥7) 个体患喘的风险降低了42% (HR:0.58;95% CI:0.36-0.95;p-trend=0.02).
结论:
- 这项研究提供了证据,表明更坚持地中海饮食和成人喘发病率较低之间存在显著联系.
- 强调MedDiet作为地中海人口中预防成人发作喘的保护性饮食因素的潜在作用.
- 建议强调MedDiet的饮食干预可以作为预防喘的策略.
相关概念视频
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification
4.5K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.5K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K


